Comments: want to watch the "blacklist" drug firms make a comeback 
 
 
The 2014-11-28 14:46:40 
 
 
Source: guangzhou daily 

    Due to bribe hospital, a pharmaceutical enterprise has become the chongqing medical procurement field of commercial bribery record listing since the first "listed", the public medical institutions in the city for two years sales and medicine exchange traded. (on November 26, the official xinhua news agency)
 
    Pharmaceutical industry relating to common people life safety and health of body and mind, see the industry enterprise business bribery record was exposed, was also banned sales and trading, greatly really is. Late last year, the national health development planning commission issued "about building the regulation of commercial bribery bad record" pharmaceutical sales field, to set up a corresponding "blacklist" system, this year on March 1, since the implementation of the system, there appeared a nationwide released real-name bribery phenomenon of pharmaceutical enterprises. It should be said that this has a name, company name and the specific plot "by name" bribery exposure, deterrent to the industry of commercial bribery, to a certain extent to curb the momentum of the spread of bribery.
 
    For a long time, the pharmaceutical industry sales of commercial bribery, bribery into industry rules. Review past medical corruption cases found that commercial bribery has infiltrated every corner of the pharmaceutical industry. Bribery in the way, is either a red envelope, commissions, fees, type of private property "gift", either travel, anniversary gifts, to help families of hospital leadership work, with a doctor the child shopping shopping feelings "pr", even a female medical generation with hospitals, doctors sleep body leadership "deal". Bribery main body has spread from local companies to international giants, last two famous international drug firms glaxosmithkline and astrazeneca are encountering "bribery", which is the best example. As for bribery object, but also a role interlocking, from technician to prescribe medicine doctor, led to the medical institutions and subsequently lok ma's food and drug administration officials.
 
    Commercial bribery of the direct influence is "bad money away good money", legitimate business enterprise existing space was squeezed, industry market is no longer a fair and orderly; And ultimately lies in the fact that all the mess has to rely on people to pay, lead to drug prices overall a mess, some drug prices artificially high, folk nitpick than this. "Blacklist" timely appear, to the chaos of the pharmaceutical industry is blowing a breeze. However, just as the wind not to walk the fog haze, commercial bribery "blacklist" system is difficult to cure, as long as bribery is still in demand, medical bribery this pool wastewater is difficult to remove.
 
    On the one hand, medical bribery driven by industry system, due to inadequate public health services, medical institutions rely on "medicine for the medical" for a long time, caused the hospital profits impulse, also gave the drug firms "gaming" of space; The pharmaceutical industry, on the other hand, the lack of institutional guarantee, "medicine for the medical" an open hole, a variety of interests are involved, combined with leading medical institutions, medical staff income is low, there is no lack of the motive of bribery; Moreover, the effect of "blacklist" itself is worrying, past the central issued documents for medical bribery regulation for many times, has always been "take temporary solution not effect a permanent cure", only to play the briber, did not punish bribery "blacklist", I'm afraid not to tickle industry corruption.
 
    What's more, the blacklist "listed" drug firms banned the sale of punishment, the time limit for two years, the limited time in the city, regional type cap public medical institutions. Drug firms can foster a completely, or to replace bribery object with the private sector, or change to other cities of bribery, or "comeback" two years later, continue to bribery.
 
    No matter from which point of view, is a "blacklist" is not clear medical bribery, more than the medicine of the treatment drug prices artificially high. Drug prices return to rational, also must hope that medicine separation, increased investment in health break to medicine cure. On this basis, supplemented by medical ethics awaken, reshape the industry discipline, supervision measures to improve, to the health care industry better add brick addition to the rampant. (Tang Jinfeng)